Apotex Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Apotex Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013558
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Apotex Inc (Apotex) produces and markets a wide range of generic pharmaceuticals. It also undertakes the research, development, manufacture and distribution of non-prescription and private label medicines, fine chemicals and disposable plastics for medical use. The company has research and development (R&D) facilities in Richmond Hill, Toronto, Etobicoke, Brantford, Windsor and Winnipeg. It has manufacturing and distribution facilities across the world and offers its products to patients, healthcare providers and payers, governments and other pharmaceutical manufacturers the world over. It operates through subsidiaries, joint ventures and licensing agreements in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Apotex is headquartered in Toronto, Ontario, Canada.

Apotex Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Apotex Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Apotex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Apotex Inc, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Charterhouse Capital Partners Acquires Doc Generici For US$424 Million 10
Licensing Agreements 12
Panacea Biotec Expands Licensing Agreement with Apotex 12
Stada Arzneimittel Enters Into License Agreement With Apotex For Filgrastim 13
Cangene Enters Into Licensing Agreement With Apotex For Biotech Drugs 15
Acquisition 16
Apotex Acquires Aveva Drug Delivery Systems From Nitto Denko 16
Apotex Inc – Key Competitors 17
Apotex Inc – Key Employees 18
Apotex Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 21
Legal and Regulatory 21
Oct 03, 2016: Apotex Files Lawsuit Seeking Compensation for “Improper” Government Actions 21
Other Significant Developments 22
Mar 08, 2017: Apotex Announces $184 Million Investment to Grow U.S. Manufacturing Presence; Expansion Plan Comprises Company’s Largest Investment in the United States 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Apotex Inc, Pharmaceuticals & Healthcare, Key Facts 2
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Apotex Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Apotex Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Apotex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Charterhouse Capital Partners Acquires Doc Generici For US$424 Million 10
Panacea Biotec Expands Licensing Agreement with Apotex 12
Stada Arzneimittel Enters Into License Agreement With Apotex For Filgrastim 13
Cangene Enters Into Licensing Agreement With Apotex For Biotech Drugs 15
Apotex Acquires Aveva Drug Delivery Systems From Nitto Denko 16
Apotex Inc, Key Competitors 17
Apotex Inc, Key Employees 18
Apotex Inc, Subsidiaries 19

★海外企業調査レポート[Apotex Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • JSFC Sistema (AFKS):石油・ガス:M&Aディール及び事業提携情報
    Summary JSFC Sistema (Sistema) is a diversified holding company which offers a wide range of consumer services in Russia and the Commonwealth of Independent States (CIS).The company undertakes businesses in various sectors, including telecommunications, high technology, real estate development, reta …
  • Green Highland Renewables Ltd:電力:M&Aディール及び事業提携情報
    Summary Green Highland Renewables Ltd (GHRL), formerly Green Highlander Renewables Limited, a subsidiary of Ancala Partners LLP, is a renewable energy company that develops, builds, and maintains hydro electric schemes. The company provides services including site identification, environmental appra …
  • Sterling Energy plc (SEY):企業の財務・戦略的SWOT分析
    Summary Sterling Energy Plc (Sterling) is an oil and gas company that offers oil and gas exploration and development services. The company acquires, produces, operates, manages, and develops crude oil and natural gas producing assets. It operates and manages oil and gas exploration projects such as …
  • Lightbridge Corporation (LTBR):企業の財務・戦略的SWOT分析
    Lightbridge Corporation (LTBR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Tenth Avenue Petroleum Corp (TPC):石油・ガス:M&Aディール及び事業提携情報
    Summary Tenth Avenue Petroleum Corp (TPC), formerly Jadela Oil Corp is an oil and gas company that explores and develops petroleum and natural gas properties in Western Canada. The company explores and develops Eagle Ford Shale in Eagle Pass of Maverick County, Texas. It operates an oilfield water d …
  • GridPoints Inc:企業の戦略的SWOT分析
    GridPoints Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Taubman Centers Inc:企業の戦略的SWOT分析
    Taubman Centers Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Alsea SAB de CV:企業の戦略・SWOT・財務情報
    Alsea SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Alsea SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Nissan Motor Co., Ltd.:企業の戦略・SWOT・財務分析
    Nissan Motor Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nissan Motor Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • TIVIT Terceirizacao de Tecnologia e Servicos SA:企業の戦略的SWOT分析
    TIVIT Terceirizacao de Tecnologia e Servicos SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • M.D.C. Holdings Inc:戦略・SWOT・企業財務分析
    M.D.C. Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary M.D.C. Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • China Food Company PLC :企業の戦略・SWOT・財務情報
    China Food Company PLC - Strategy, SWOT and Corporate Finance Report Summary China Food Company PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Centene Corp (CNC):製薬・医療:M&Aディール及び事業提携情報
    Summary Centene Corp (Centene) is a healthcare service provider that offers services to government sponsored healthcare programs with focus on under-insured and uninsured individuals. It provides health plans through Medicaid, Medicare and Health Insurance Marketplace contracts; and other health sol …
  • Aesculap Inc-医療機器分野:企業M&A・提携分析
    Summary Aesculap Inc (Aesculap) is a medical device company that offers medical implants, surgical implants, and other related devices. The company’s products comprise neurosurgery products, power systems, sterile processing products, surgical instruments, and wound closure products. It offers servi …
  • CoLucid Pharmaceuticals Inc (CLCD)-製薬・医療分野:企業M&A・提携分析
    Summary CoLucid Pharmaceuticals Inc (CoLucid) is a pharmaceutical company that conducts research and develops new therapies. CoLucid’s lead product candidate Lasmiditan (COL-144), is an oral tablet that penetrates the central nervous system and selectively targets 5-HT1F receptors expressed in the t …
  • Santos Ltd (STO):石油・ガス:M&Aディール及び事業提携情報
    Summary Santos Ltd (Santos) is an independent oil and natural gas company. Its activities include onshore, offshore and liquefied natural gas (LNG) projects. The company has exploration and production acreage in Australia and Papua New Guinea. Its core natural gas assets include Cooper Basin, Queens …
  • Royal BAM Group nv:戦略・SWOT・企業財務分析
    Royal BAM Group nv - Strategy, SWOT and Corporate Finance Report Summary Royal BAM Group nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Bangkok Chain Hospital Public Co Ltd (BCH):企業の財務・戦略的SWOT分析
    Bangkok Chain Hospital Public Co Ltd (BCH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Noor Takaful:企業の戦略・SWOT・財務情報
    Noor Takaful - Strategy, SWOT and Corporate Finance Report Summary Noor Takaful - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Arlington Asset Investment Corp (AI):企業の財務・戦略的SWOT分析
    Summary Arlington Asset Investment Corp (AAIC) is an investment firm that offers asset management and investment services. The firm acquires and holds mortgage-related assets. It acquires residential mortgage-backed securities issued by the US government agencies. AAIC also acquires mortgage-backed …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆